- Home
- A-Z Publications
- Current Diabetes Reviews
- Previous Issues
- Volume 21, Issue 7, 2025
Current Diabetes Reviews - Volume 21, Issue 7, 2025
Volume 21, Issue 7, 2025
-
-
In-Vitro and In-Silico Studies of Brevifoliol Ester Analogues against Insulin Resistance Condition
BackgroundBrevifoliol is a diterpenoid that occurs naturally in the plants of Taxus genus and is widely used as chemotherapy agent for the management of cancer. A series of semisynthetic esters analogues of brevifoliol were prepared by Steglich esterification and attempted for their pharmacological potential against insulin resistance conditions using in-vitro and in-silico assays.ObjectiveThe aim of this study is to und Read More
-
-
-
Comorbidity of Depression and Diabetes: A Literature Review on Systemic Flaws in Healthcare and the Benefits of Collaborative Diagnosis and Treatment in Primary Care Settings
BackgroundThe increasing specialization and dispersion of healthcare systems have led to a shortage of resources to address comorbidities. Patients with coexisting mental and physical conditions are disadvantaged, as medical providers often only focus on the patient's mental illness while neglecting their physical needs, resulting in poorer health outcomes.ObjectiveThis study aimed to shed light on the systemic flaws i Read More
-
-
-
An Overview on Diabetic Neuropathy
Authors: Ujjawal Singh, Ramsha Sharma and Ranjeet KumarThe term “Diabetic neuropathy” refers to a collection of clinical and subclinical symptoms caused by problems with the peripheral nervous system. Diabetes, which affects approximately 381 million people worldwide, is the source of dysfunction due to the emergence of microvascular complications. It is anticipated that in the next ten years, Diabetic neuropathy will manifest in about 50% of patients who are currently di Read More
-
-
-
Diabetic Retinopathy-A Review
Authors: D. S. Pushparani, J. Varalakshmi, K. Roobini, P. Hamshapriya and A. LivithaDiabetic Retinopathy is a vascular microvascular disease also called diabetic eye disease caused by microangiopathy leading to progressive damage of the retina and blindness. The uncontrolled blood glycemic level or sugar level results in diabetic retinopathy.There are two stages of diabetic retinopathy: proliferative diabetic retinopathy and non-proliferative diabetic retinopathy. Symptoms of diabetic retinopathy ofte Read More
-
-
-
Correlation between Serum 25 (OH) D Levels with Insulin Resistance and Metabolic Associated Fatty Liver Disease - A Retrospective Study based on Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Authors: Xin Zhao, Jianbin Sun, Sixu Xin, Xiumei Xu and Xiaomei ZhangAimsThe objective of this study was to investigate the correlation between serum 25 hydroxyvitamin D [25(OH)D] levels and insulin resistance, as well as metabolic associated fatty liver disease (MAFLD) in newly diagnosed with type 2 diabetes mellitus (T2DM) patients.MethodsA retrospective analysis was conducted on 491 T2DM patients who were newly diagnosed between January 2017 and August 2022 at Peking University I Read More
-
-
-
Characterization of Green Synthesized Nanoparticles with Anti-diabetic Properties. A Systematic Review
BackgroundPlants are used in medicine because they are low-cost, widely available, and have few side effects (compared to pharmacological treatment). Plants have phytocompounds with antidiabetic properties that can be delivered using nanoparticles (NPs).ObjectiveTo describe the antidiabetic properties of green synthesized NPs (GSNPs) and their characterization methods.MethodsThree databases were consulted u Read More
-
-
-
Efficacy of Adjunctive Local Antimicrobials to Non-Surgical Periodontal Therapy in Pocket Reduction and Glycemic Control of Patients with Type 2 Diabetes: A Network Meta-Analysis
ObjectiveThis network meta-analysis [NMA] investigated the efficacy of adjunctive use of subgingivally delivered antimicrobials to non-surgical periodontal therapy [NSPT] in the glycemic control and periodontal pocket depth (PPD) reduction in patients with type 2 diabetes (T2D).MethodsSeven databases, grey literature, and registry platforms were searched up to February 2024 to identify randomized clinic Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cdr
Journal
10
5
false
en
